Aurobindo Pharma LtdNSE: AUROPHARMA

Press Release Jul 25 2023

· Issued by Aurobindo Pharma Ltd

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jul-25-2023-4

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated July 25, 2023, titled "Eugia Pharma receives USFDA Approval for Plerixafor Injection, 24 mg/1.2 mL (20 mg/mL), Single-Dose Vial".

View Attachment

6ix hasn’t read this filing yet.

Aurobindo Pharma Ltd on 6ix

Earlier from Aurobindo Pharma

Later from Aurobindo Pharma

All Aurobindo Pharma news releases